Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

University of Pavia

Status: Completed

Conditions: Diabetes; End Stage Renal Disease

Treatments: Device: Continuous Glucose Monitoring (CGM)

Study type: Observational

Funder types: Other

Identifiers

NCT01049152

20090003173

Details and patient eligibility

About

Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.

Enrollment: 36 patients

Sex: All

Ages: 50 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with or without diabetes mellitus
• ESRD
• undergone hemodialysis
• males and females aged 50-80

Exclusion criteria

• tumors
• chronic inflammation diseases
• AMI
• acute pulmonary diseases

Trial design

36 participants in 2 patient groups

nondiabetic patients

Description:

nondiabetic patients with ESRD undergone hemodialysis

Treatment:

Device: Continuous Glucose Monitoring (CGM)

diabetic patients

Description:

diabetic patients with ESRD undergone hemodialysis

Treatment:

Device: Continuous Glucose Monitoring (CGM)